SLC3A2 and mature T-cell and NK-cell non-Hodgkin lymphoma: To further assess the role of SSRP1 in SLC3A2 expression, we used CRISPR editing, as confirmed by immunoblotting, to knockout SSRP1 in PTCL cells (H9 and SU‐DHL‐1).